TickerFactsScreenerDevelopers

Minerva Neurosciences, Inc. (NERV) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: $3.09M2018: -$41.94M2019: -$43.43M2020: -$33.82M2021: -$24.60M2022: -$24.65M2023: -$14.78M2024: -$19.55M2025: -$13.51M-$13.51M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$13.51M+30.9%
2024-$19.55M-32.2%
2023-$14.78M+40.0%
2022-$24.65M-0.2%
2021-$24.60M+27.3%
2020-$33.82M+22.1%
2019-$43.43M-3.6%
2018-$41.94M-1456.1%
2017$3.09M—